These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11750032)
1. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice. Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032 [TBL] [Abstract][Full Text] [Related]
2. A new halogenated antidiabetic vanadyl complex, bis(5-iodopicolinato)oxovanadium(IV): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis. Takino T; Yasui H; Yoshitake A; Hamajima Y; Matsushita R; Takada J; Sakurai H J Biol Inorg Chem; 2001 Feb; 6(2):133-42. PubMed ID: 11293406 [TBL] [Abstract][Full Text] [Related]
3. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics. Yasui H; Tamura A; Takino T; Sakurai H J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid. Nakai M; Obata M; Sekiguchi F; Kato M; Shiro M; Ichimura A; Kinoshita I; Mikuriya M; Inohara T; Kawabe K; Sakurai H; Orvig C; Yano S J Inorg Biochem; 2004 Jan; 98(1):105-12. PubMed ID: 14659639 [TBL] [Abstract][Full Text] [Related]
5. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV). Sakurai H; Fujii K; Watanabe H; Tamura H Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515 [TBL] [Abstract][Full Text] [Related]
6. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies. Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542 [TBL] [Abstract][Full Text] [Related]
7. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA)-release in isolated rat adipocytes. Adachi Y; Sakurai H Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):428-33. PubMed ID: 15056957 [TBL] [Abstract][Full Text] [Related]
8. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus. Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860 [TBL] [Abstract][Full Text] [Related]
9. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats. Sakurai H; Sano H; Takino T; Yasui H J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469 [TBL] [Abstract][Full Text] [Related]
10. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds. Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797 [TBL] [Abstract][Full Text] [Related]
11. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes. Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643 [TBL] [Abstract][Full Text] [Related]
12. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode. Rangel M; Tamura A; Fukushima C; Sakurai H J Biol Inorg Chem; 2001 Feb; 6(2):128-32. PubMed ID: 11293405 [TBL] [Abstract][Full Text] [Related]
15. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities. Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366 [TBL] [Abstract][Full Text] [Related]
16. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes. Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407 [TBL] [Abstract][Full Text] [Related]
17. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat. Yasui H; Adachi Y; Katoh A; Sakurai H J Biol Inorg Chem; 2007 Aug; 12(6):843-53. PubMed ID: 17503093 [TBL] [Abstract][Full Text] [Related]
18. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies. Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195 [TBL] [Abstract][Full Text] [Related]
19. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode. Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238 [TBL] [Abstract][Full Text] [Related]
20. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells. Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]